Sort
4,870 grants matching “glp 1”
A Novel Myeloperoxidase Inhibitor for Treating Multiple Sclerosis
$285,790Stephen Naylor · Reneurogen, Llc · R43 · FY2018 · NS
Novel Long Acting rhTSH Superagonist Analogs for Improved Diagnostic Imaging, Thyroglobulin Stimulation and Therapy of Thyroid Cancer.
$285,070Bruce Dale Weintraub · Trophogen, Inc. · R44 · FY2018 · CA
Product Development and Manufacturing Core
$284,979Becky L Rivoire Phd · Colorado State University · U54 · FY2011 · AI
Cyclic Orynotides for Systemic MDR Candidiasis
$284,978Dat Quang Tran · Oryn Therapeutics, Llc · R44 · FY2019 · AI
Central Viscerosensory Circuits-Structure and Function
$284,376Linda M Rinaman · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · MH
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)
$284,071David Harlan · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Osteopontin-targeted therapy for primary CNS lymphoma
$283,986John A Copland · Modulation Therapeutics, Inc. · R41 · FY2017 · CA
SmartInsulin Stability, Process Development, Assay Validation and GMP Manufacturi
$283,515Todd C Zion · Smartcells, Inc. · R44 · FY2007 · DK
Sex-specific factors, inflammation and vascular health across the lifespan in women living with HIV
$283,500Allison G Hays · Johns Hopkins University · R35 · FY2024 · HL
Biomarker Developmental Unit
$283,024Cecilia C Yeung · Fred Hutchinson Cancer Center · U2C · FY2022 · CA
Bisphenol A and the Metabolic Syndrome: Focus on Adipose Tissue Functions
$282,600Nira Ben-Jonathan · University Of Cincinnati · U01 · FY2012 · ES
Metabolic effects of non-nutritive sweeteners
$281,855Kristina Rother · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Sex-specific factors, inflammation and vascular health across the lifespan in women living with HIV
$281,116Allison G Hays · Johns Hopkins University · R35 · FY2025 · HL
Pediatric Type 1 Diabetes: Intervention Trials With Glucagon Suppressors
$280,292Rubina A Heptulla · Albert Einstein College Of Medicine · R01 · FY2010 · DK
L-type Ca2+ channel modulation of beta cell function
$280,238Gregory Howard Hockerman · Purdue University · R01 · FY2011 · DK
ROLE OF PRESENILIN IN NOTCH AND APP MATURATION
$280,170Washington University · R01 · FY2002 · AG
Novel peptide therapeutics to treat cystic fibrosis-related diabetes
$280,122Robert Schotzinger · Eldec Pharmaceuticals, Inc. · R42 · FY2025 · DK
Rodent pancreatic islet biology in health and disease
$279,534David Harlan · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Inpatient and outpatient infrastructure for T1DM clinical protocols
$279,534David Harlan · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
L-type Ca2+ channel modulation of beta cell function
$279,409Gregory Howard Hockerman · Purdue University · R01 · FY2012 · DK
Novel SCD1 inhibitors for treatment of cancer
$279,000Lori Hazlehurst · Modulation Therapeutics, Inc. · R41 · FY2016 · CA
Sleep deprivation and energy balance
$278,981Marie-Pierre St-Onge · St. Luke'S-Roosevelt Inst For Hlth Scis · R01 · FY2009 · HL
Therapeutic targets in African-American youth with type 2 diabetes
$278,804Stephanie Therese Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
PROLIFERATIVE VS MEIOTIC FATE DECISION IN C. ELEGANS
$278,692Tim B. Schedl · Washington University · R01 · FY2013 · GM
REPRESSIVE HISTONE AND DNA METHYLATION IN RODENT DEPRESSION MODELS
$278,583Eric J Nestler · Icahn School Of Medicine At Mount Sinai · P50 · FY2013 · MH